1 of 1
Story summary
- The CNBC Investing Club's April meeting discussed stocks amid a market rebound after the S&P 500's record high.
- Jim Cramer of CNBC Investing Club urged investors to stay invested despite Iran-war uncertainties.
- DuPont is positioned for global trends.
- Eli Lilly is noted for GLP-1 treatments.
- In the discussion, Boeing's strong order book and Eaton's potential acquisition of Boyd Thermal were noted, with no outcomes guaranteed.
